Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF

Conditions

Pulmonary Fibrosis

What is the purpose of this trial?

Idiopathic pulmonary fibrosis (IPF) is a long-term lung disease that affects an individual's ability to breathe. This study will evaluate the effectiveness of the antioxidant N-acetylcysteine (NAC), at preventing the loss of lung function in people with IPF.



Participation Guidelines

Age:
35 Years - 85 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Duke University
National Heart, Lung, and Blood Institute (NHLBI)
Dates:
October 2009
Last Updated:
May 19, 2014
Study HIC#:

Clinicaltrials.gov ID: NCT00650091